Navigation Links
Dehaier Medical Announces First Quarter 2011 Financial Results
Date:5/4/2011

primarily attributable to the discontinuation of our distributed homecare products to focus on its branded products. As the Company gains additional market traction and launches new branded products for the homecare market later this year, Dehaier expects its homecare product sales to increase.

Gross ProfitGross profit for the three months ended March 31, 2011 increased slightly to $1.00 million, compared with $0.97 million for the three months ended March 31, 2010. As a percentage of revenue, the Company's gross margin was 34% for the three months ended March 31, 2011, compared with 37% for the same period in 2010. The decrease in gross margin was primarily due to the increase of registration fees for new homecare products and renewal for existing products and fixed assets depreciation.

Income from OperationsOperating income for the three months ended March 31, 2011 totaled $298,000, compared with $648,000 for the three months ended March 31, 2010.

Operating expenses for the quarter totaled $0.74 million, an increase of 90%, compared with $0.39 million for the same period a year ago. The increase in operating expenses was largely attributable to a $0.28 million increase in general and administrative expense associated with being a publicly traded company, including costs of maintaining and enhancing our internal controls and other public company-related expenses, and associated with the build of five new CECs.

Net IncomeNet income attributable to the Company for the three months ended March 31, 2011 was $0.21 million, compared with $0.52 million for the three months ended March 31, 2010. The decrease in net income was primarily due to increased operating expenses as the Company made investments in its infrastructure during the first quarter to support its expected growth. Earnings per diluted share was $0.04, based on 4.7 million shares outstanding for the quarter, compared w
'/>"/>

SOURCE Dehaier Medical Systems Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Dehaier Medical to Report First Quarter 2011 Financial Results on May 4
2. Dehaier Medical Chairman and CEO Issues Letter to Shareholders
3. Dehaier Medical Systems Signs New Distribution Agreement to Distribute eVent Medical Ventilators
4. Dehaier Medical Announces Fourth Quarter and Full-Year 2010 Financial Results
5. Dehaier Medical to Report Fourth Quarter and Full-Year 2010 Financial Results on March 7
6. Dehaier Medical Announces March Investor Presentations
7. Dehaier Medical Retains The Piacente Group as Strategic Investor Relations Consulting Firm
8. Dehaier Medical Announces Participation in Arab Health 2011
9. Dehaier Medical Announces Third Quarter 2010 Financial Results
10. Dehaier Medical Announces Conference Call to Discuss Third Quarter 2010 Financial Results
11. Dehaier Medical to Participate in MEDICA International Trade Fair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 10, 2014  Breg, Inc., a premier ... launched the FreeRunner™ knee brace with new innovations ... patella mal-tracking return to active lifestyles.  FreeRunner,s patent-pending ... braces, providing support when patients need it most, ... don,t. Patellofemoral issues are the most ...
(Date:7/10/2014)... , July 10, 2014  BC Technical, the largest ... MiE America , Inc., a leading provider of Siemens ... a long-term agreement naming BC Technical as the authorized ... MiE and BC Technical announced today that ... establish BC Technical as the service and systems provider ...
(Date:7/10/2014)... Israel , July 10, 2014   ... Diabetes Management Solution, today announced the appointment of ... independent member of its Board of Directors. ... legal and business experience to LabStyle as an ... and legal and corporate governance expert. He currently ...
Breaking Medicine Technology:Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4
... 2011 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group ("Simcere" or the ... company specializing in the development, manufacturing, and marketing of ... financial results for the fourth quarter and fiscal year ... Total revenue was RMB587.7 million (US$89.1 million) for ...
... board of directors of Hospira, Inc. (NYSE: HSP ... announced the election of F. Michael (Mike) Ball as the ... the board, effective March 28, 2011. Mr. Ball, 55, currently ... Begley, who will assume the role of executive chairman. ...
Cached Medicine Technology:Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2010 Results 2Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2010 Results 3Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2010 Results 4Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2010 Results 5Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2010 Results 6Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2010 Results 7Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2010 Results 8Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2010 Results 9Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2010 Results 10Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2010 Results 11Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2010 Results 12Hospira Board Names F. Michael Ball New CEO; Christopher B. Begley to Assume Executive Chairman Role 2Hospira Board Names F. Michael Ball New CEO; Christopher B. Begley to Assume Executive Chairman Role 3Hospira Board Names F. Michael Ball New CEO; Christopher B. Begley to Assume Executive Chairman Role 4
(Date:7/11/2014)... enterprises today are shifting towards the changing trend in ... offer these global enterprises a strategic method to cut ... operational costs to companies. The aim to minimize operational ... market driver for expanding the managed services market in ... estimated to grow from $142.75 billion in 2013 to ...
(Date:7/11/2014)... 11, 2014 As reported by the ... (Weintraub 7/11/14), a significant number of severe adverse events ... issues and even death from the highly-promoted and costly ... the Times report , a regulatory filing revealed ... by patients was almost 14% of prescriptions, up from ...
(Date:7/11/2014)... Wash.The largest study of its kind has found ... of advantages over their conventional counterparts, including more ... The study looked at an unprecedented 343 peer-reviewed ... organic and conventional plant-based foods, including fruits, vegetables, ... techniques to quantify differences between organic and non-organic ...
(Date:7/11/2014)... Steven Reinberg HealthDay ... A potential vaccine to protect children from the worldwide scourge ... Asian children. While the vaccine only prevented dengue fever ... full series of three shots, it protected more than 88 ... dengue fever can lead to hospitalization, and sometimes death. ...
(Date:7/11/2014)... Ticket Down is a reliable source for cheap ... in Wheatland, CA. In the Sacramento California area there ... Train Amphitheatre can do for music fans. The venue has ... of its existence and can seat 18,500 fans each night. ... metro area) will host the “That’s My Kind of Night” ...
Breaking Medicine News(10 mins):Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 4Health News:Acthar’s Deadly Adverse Events Revealed 2Health News:Acthar’s Deadly Adverse Events Revealed 3Health News:Major study documents nutritional and food safety benefits of organic farming 2Health News:Major study documents nutritional and food safety benefits of organic farming 3Health News:Dengue Fever Vaccine Shows Some Promise in Trial 2Health News:Dengue Fever Vaccine Shows Some Promise in Trial 3Health News:Luke Bryan Tickets Sleep Train Amphitheatre in Wheatland, CA (Sacramento): Ticket Down has Slashed Ticket Prices on Luke Bryan in Wheatland at Sleep Train 2Health News:Luke Bryan Tickets Sleep Train Amphitheatre in Wheatland, CA (Sacramento): Ticket Down has Slashed Ticket Prices on Luke Bryan in Wheatland at Sleep Train 3
... a key molecule that controls the growth, spread and survival ... toward new and better treatment options for pancreatic cancer . ... Beta molecule plays in pancreatic cancer and that they have ... and survival through its effect on NF Kappa B -- ...
... the drug alendronate (Fosamax) can reduce the risk of vertebral ... not osteoporosis. 3,737 postmenopausal women between ages 55 and 80 ... -2.5 were evaluated . About half the women randomly received ... thereafter while the other half took a placebo. ,The ...
... its growth factors aren’t just produced in the pancreas, but ... areas of the brain//, the result can be brain cell ... people with Alzheimer’s. ,The research was conducted in rats, ... IGF I and IGF II were produced in the nerve ...
... well known that HIV patients are at an increased risk ... study shows // aggressive antiretroviral therapy may help lower that ... antiretroviral therapy was associated with a lower incidence of Kaposi ... on more than 7,300 patients infected with HIV and the ...
... Intravenous administration of the drug tezosentan did not improve worsening ... failure // despite high hopes. The above fact was found ... to date. The study was conducted to evaluate if something ... order to speed up hospital discharge and prevent them from ...
... that how much we drink may be decided by a ... gene called DRD2 Taq1A(C32806T) polymorphism and social alcohol drinking may ... stronger gene of this type will tend to drink alcohol ... The gene is responsible for enhancing the pleasure that is ...
Cached Medicine News:
... The Perfect Single Vac Manifold ... 96-well plate in 30 minutes; ... an "open/closed" switch and a ... easy operation. contains vacuum chamber, ...
... Workstations from Caliper provide an automated alternative to Kuderna-Danish, Rotary, Vacuum-Style and Nitrogen Blow-Down Evaporators. For over ... world today. ... ... ...
QIAvac 96 is designed for efficient processing of QIAGEN 96-well plates....
For processing mini spin columns on QIAvac 6S;...
Medicine Products: